Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-297558 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 7, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
18,000
Total Value
$176,689.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jul 6, 2026 | Exercise/Conversion | 6,000 | $6.14 | $36,840.00 | 73,845 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jul 6, 2026 | Sale | 5,600 | $23.25 | $130,197.20 | 68,245 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jul 6, 2026 | Sale | 400 | $24.13 | $9,652.00 | 67,845 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Jul 6, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 197,290 | Direct | โ | View Details |